Rapid ASPECTS (v3)

iSchemaView, Inc. · K232156 · 2024-01-19

Rapid ASPECTS (v3) is an AI-enabled medical device from iSchemaView, Inc., listed by FDA (510(k), K232156) with a decision date of 2024-01-19. Review panel: Radiology.

FDA submission numberK232156
Pathway510(k)
CompanyiSchemaView, Inc.
Review panel (specialty)Radiology
FDA decision date2024-01-19
DecisionSubstantially Equivalent
Product codePOK
ClassificationComputer-Assisted Diagnostic Software For Lesions Suspicious For Cancer
Device class2
Regulation number892.2060
Review time (calendar days)183
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

More devices from iSchemaView, Inc. · All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.